Medicamen Biotech Fundamental Analysis
MEDICAMEQ
275.450.00 (0.00%)
Last updated on 11 Nov, 2026 | 15:31 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Medicamen Biotech Fundamentals
P/E Ratio
36.1
P/B Ratio
1.37
Div. Yield
0.36
Sector P/E
40.97
Sector P/B
3.82
Sec. Div. Yield
0.53
Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 36.1, compared to the sector average of 40.97. Its P/B Ratio stands at 1.37, while the sector’s is 3.82. In terms of returns, the stock offers a Dividend Yield of 0.36%, which is than the sector’s 0.53%.
Medicamen Biotech Score Card
Price
Attractive
Growth
Poor
Quality
Poor
Management
Good
On its scorecard, Medicamen Biotech reflects: Price – Attractive, Growth – Poor, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in MEDICAMEQ
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC